His lab is focusing on refining the alanine-scanning assay to a few key residues which will accurately distinguish involving fibrils from neurodegenerative tauopathies. He envisions making use of this streamlined assay for postmortem neuropathological analysis, And maybe for blood screening of tauopathies.Despite these promising innovations, you wi